1 |
Zupancic M, Näsman A, Berglund A, Dalianis T, Friesland S. Adenoid Cystic Carcinoma (AdCC): A Clinical Survey of a Large Patient Cohort. Cancers (Basel) 2023;15. [PMID: 36900288 DOI: 10.3390/cancers15051499] [Reference Citation Analysis]
|
2 |
Mukherjee S, Mukherjee SB, Frenkel-Morgenstern M. Functional and regulatory impact of chimeric RNAs in human normal and cancer cells. Wiley Interdiscip Rev RNA 2023;:e1777. [PMID: 36633099 DOI: 10.1002/wrna.1777] [Reference Citation Analysis]
|
3 |
Parikh AS, Wizel A, Davis D, Lefranc-Torres A, Rodarte-Rascon AI, Miller LE, Emerick KS, Varvares MA, Deschler DG, Faquin WC, Aster JC, Lin DT, Bernstein BE, Drier Y, Puram SV. Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma. Cell Rep 2022;41:111743. [PMID: 36450256 DOI: 10.1016/j.celrep.2022.111743] [Reference Citation Analysis]
|
4 |
Ferrarotto R, Mishra V, Herz E, Yaacov A, Solomon O, Rauch R, Mondshine A, Motin M, Leibovich-Rivkin T, Davis M, Kaye J, Weber CR, Shen L, Pearson AT, Rosenberg AJ, Chen X, Singh A, Aster JC, Agrawal N, Izumchenko E. AL101, a gamma-secretase inhibitor, has potent antitumor activity against adenoid cystic carcinoma with activated NOTCH signaling. Cell Death Dis 2022;13:678. [PMID: 35931701 DOI: 10.1038/s41419-022-05133-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
5 |
Mukherjee SB, Mukherjee S, Frenkel-Morgenstern M. Fusion proteins mediate alternation of protein interaction networks in cancers. Adv Protein Chem Struct Biol 2022;131:165-76. [PMID: 35871889 DOI: 10.1016/bs.apcsb.2022.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Tang YF, Wu WJ, Zhang JY, Zhang J. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in adenoid cystic carcinoma of the salivary gland. Transl Cancer Res 2021;10:5133-49. [PMID: 35116364 DOI: 10.21037/tcr-21-1771] [Reference Citation Analysis]
|
7 |
Toper MH, Sarioglu S, Skálová A. Biomarkers in Head and Neck Carcinomas. Biomarkers in Carcinoma of Unknown Primary 2022. [DOI: 10.1007/978-3-030-84432-5_4] [Reference Citation Analysis]
|
8 |
Todd R. The Molecular Biology of Benign and Malignant Salivary Gland Tumors. Salivary Gland Pathology 2021. [DOI: 10.1002/9781119730248.ch9] [Reference Citation Analysis]
|
9 |
Mukherjee S, Heng HH, Frenkel-Morgenstern M. Emerging Role of Chimeric RNAs in Cell Plasticity and Adaptive Evolution of Cancer Cells. Cancers (Basel) 2021;13:4328. [PMID: 34503137 DOI: 10.3390/cancers13174328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
10 |
Shibata E, Morita KI, Kayamori K, Tange S, Shibata H, Harazono Y, Michi Y, Ikeda T, Harada H, Imoto I, Yoda T. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:426-33. [PMID: 34413003 DOI: 10.1016/j.oooo.2021.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
11 |
Wang F, Xi SY, Hao WW, Yang XH, Deng L, Xu YX, Wu XY, Zeng L, Guo KH, Wang HY. Mutational landscape of primary pulmonary salivary gland-type tumors through targeted next-generation sequencing. Lung Cancer 2021;160:1-7. [PMID: 34364112 DOI: 10.1016/j.lungcan.2021.07.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
12 |
Malignant Epithelial Neoplasms. Tumors of the Salivary Glands 2021. [DOI: 10.55418/9781933477947-06] [Reference Citation Analysis]
|
13 |
Toper MH, Sarioglu S. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective. Adv Anat Pathol 2021;28:81-93. [PMID: 33405400 DOI: 10.1097/PAP.0000000000000291] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
|
14 |
Krifa M, Bdioui A, Lajmi Z, Missaoui N, Hmissa S, Mokni M. Primary adenoid cystic carcinoma of the lung: A case report and literature review. Heliyon 2021;7:e06206. [PMID: 33598583 DOI: 10.1016/j.heliyon.2021.e06206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
15 |
Huang Z, Pan J, Chen J, Wu S, Wu T, Ye H, Zhang H, Nie X, Huang C. Multicentre clinicopathological study of adenoid cystic carcinoma: A report of 296 cases. Cancer Med 2021;10:1120-7. [PMID: 33449415 DOI: 10.1002/cam4.3707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
16 |
Han J, Han N, Xu Z, Zhang C, Liu J, Ruan M. Expression profile of circular RNA and construction of circular RNA-Micro RNA network in salivary adenoid cystic carcinoma. Cancer Cell Int 2021;21:28. [PMID: 33413420 DOI: 10.1186/s12935-020-01681-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
17 |
Bankhead A, Tempel TR Jr, Flores-Hidalgo A. Mass in the floor of the mouth of an African American smoker. Oral Surg Oral Med Oral Pathol Oral Radiol 2020:S2212-4403(20)31338-9. [PMID: 33342717 DOI: 10.1016/j.oooo.2020.11.011] [Reference Citation Analysis]
|
18 |
Couvreur K, Celine J, Marlies B, Randal D, Philippe D, Frederic D, Sylvie R. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients. Acta Clin Belg 2020;75:362-9. [PMID: 31232197 DOI: 10.1080/17843286.2019.1633490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
19 |
Hou H, Jia D, Yan W, Zhang X, Wang C, Li Y, Chen H, Huang W, Li Z, Zhang X. KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors. Transl Cancer Res 2020;9:4703-14. [PMID: 35117834 DOI: 10.21037/tcr-20-637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
20 |
Goto K, Kajimoto K, Sugino T, Nakatsuka SI, Yoshida M, Noto M, Kono M, Takai T. MYB Translocations in Both Myoepithelial and Ductoglandular Epithelial Cells in Adenoid Cystic Carcinoma: A Histopathologic and Genetic Reappraisal in Six Primary Cutaneous Cases. Am J Dermatopathol 2021;43:278-83. [PMID: 32732690 DOI: 10.1097/DAD.0000000000001755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
21 |
Sun T, Akalin A, Dresser K, Fischer AH, Zuo T. The Utility of MYB Immunohistochemistry (IHC) in Fine Needle Aspiration (FNA) Diagnosis of Adenoid Cystic Carcinoma (AdCC). Head Neck Pathol 2021;15:389-94. [PMID: 32661670 DOI: 10.1007/s12105-020-01202-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
22 |
Li B, Jie W, He H. Myb Immunohistochemical Staining and Fluorescence in situ Hybridization in Salivary Rare Basaloid Lesions. Front Oncol 2020;10:870. [PMID: 32695659 DOI: 10.3389/fonc.2020.00870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
23 |
Moutasim KA, Thomas GJ. Salivary gland tumours: update on molecular diagnostics. Diagnostic Histopathology 2020;26:159-64. [DOI: 10.1016/j.mpdhp.2020.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
24 |
Dutta A, Arun P, Arun I. Adenoid Cystic Carcinoma with Transformation to High Grade Carcinomatous and Sarcomatoid Components: A Rare Case Report with Review of Literature. Head Neck Pathol 2020;14:1094-104. [PMID: 31898057 DOI: 10.1007/s12105-019-01120-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
25 |
Magers MJ, Iczkowski KA, Montironi R, Grignon DJ, Zhang S, Williamson SR, Yang X, Wang M, Osunkoya AO, Lopez-Beltran A, Hes O, Eble JN, Cheng L. MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia. Mod Pathol 2019;32:1666-74. [PMID: 31189999 DOI: 10.1038/s41379-019-0297-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
26 |
Pei J, Flieder DB, Patchefsky A, Talarchek JN, Cooper HS, Testa JR, Wei S. Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing. Mod Pathol 2019;32:1416-20. [PMID: 31028361 DOI: 10.1038/s41379-019-0277-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
27 |
McIntyre JB, Ko JJ, Siever J, Chan AMY, Simpson RHW, Hao D, Lau HY. MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study. Diagn Pathol 2019;14:78. [PMID: 31301736 DOI: 10.1186/s13000-019-0855-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
28 |
Thierauf J, Ramamurthy N, Jo VY, Robinson H, Frazier RP, Gonzalez J, Pacula M, Dominguez Meneses E, Nose V, Nardi V, Dias-Santagata D, Le LP, Lin DT, Faquin WC, Wirth LJ, Hess J, Iafrate AJ, Lennerz JK. Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma. Oncologist 2019;24:1356-67. [PMID: 30926674 DOI: 10.1634/theoncologist.2018-0515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
29 |
Liu C, Li S, Pang F, Wu H, Chai L, Liang C, Zhang D. Autophagy‐related gene expression regulated by HIF‐1α in salivary adenoid cystic carcinoma. Oral Dis 2019;25:1076-83. [DOI: 10.1111/odi.13058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
30 |
Liu X, Chen D, Lao X, Liang Y. The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis. Head & Neck 2019;41:1517-24. [DOI: 10.1002/hed.25597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
31 |
Cornett A, Athwal HK, Hill E, Murphy G 3rd, Yeoh K, Moskaluk CA, Witt RL, D'Silva NJ, Agarwal S, Lombaert IMA. Serial patient-derived orthotopic xenografting of adenoid cystic carcinomas recapitulates stable expression of phenotypic alterations and innervation. EBioMedicine 2019;41:175-84. [PMID: 30765319 DOI: 10.1016/j.ebiom.2019.02.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
32 |
Fry EA, Inoue K. c-MYB and DMTF1 in Cancer. Cancer Invest 2019;37:46-65. [PMID: 30599775 DOI: 10.1080/07357907.2018.1550090] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
|
33 |
Badoual C, Lépine C. Anatomopathologie. Cancers du Larynx 2019. [DOI: 10.1016/b978-2-294-76676-3.00004-5] [Reference Citation Analysis]
|
34 |
Endo Y, Kuwamoto S, Ohira T, Matsushita M, Matsushige T, Fukuhara T, Nakamoto S, Hayashi K, Kugoh H, Hirooka Y. Possible Relationship Between <i>MYBL1</i> Alterations and Specific Primary Sites in Adenoid Cystic Carcinoma: A Clinicopathological and Molecular Study of 36 Cases. Yonago Acta Med 2019;62:067-76. [DOI: 10.33160/yam.2019.03.010] [Reference Citation Analysis]
|
35 |
Mandelbaum J, Shestopalov IA, Henderson RE, Chau NG, Knoechel B, Wick MJ, Zon LI. Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma. J Exp Med 2018;215:2673-85. [PMID: 30209067 DOI: 10.1084/jem.20180939] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
|
36 |
Andreasen S. Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression. APMIS 2018;126:7-57. [DOI: 10.1111/apm.12828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
37 |
Togashi Y, Dobashi A, Sakata S, Sato Y, Baba S, Seto A, Mitani H, Kawabata K, Takeuchi K. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts. Mod Pathol 2018;31:934-46. [PMID: 29410490 DOI: 10.1038/s41379-018-0008-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 9.2] [Reference Citation Analysis]
|
38 |
Saida K, Murase T, Ito M, Fujii K, Takino H, Masaki A, Kawakita D, Ijichi K, Tada Y, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Shinomiya H, Nibu KI, Shimozato K, Inagaki H. Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma. Oncotarget 2018;9:17043-55. [PMID: 29682203 DOI: 10.18632/oncotarget.24818] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
39 |
Kim J, Geyer FC, Martelotto LG, Ng CK, Lim RS, Selenica P, Li A, Pareja F, Fusco N, Edelweiss M, Kumar R, Gularte-Merida R, Forbes AN, Khurana E, Mariani O, Badve S, Vincent-Salomon A, Norton L, Reis-Filho JS, Weigelt B. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene. J Pathol 2018;244:143-50. [PMID: 29149504 DOI: 10.1002/path.5006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 7.8] [Reference Citation Analysis]
|
40 |
Uraizee I, Cipriani NA, Ginat DT. Adenoid Cystic Carcinoma of the Oral Cavity: Radiology-Pathology Correlation. Head Neck Pathol 2018;12:562-6. [PMID: 28879643 DOI: 10.1007/s12105-017-0849-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
41 |
Fujii K, Murase T, Beppu S, Saida K, Takino H, Masaki A, Ijichi K, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Inagaki H. MYB , MYBL1 , MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma. Histopathology 2017;71:823-34. [DOI: 10.1111/his.13281] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
|
42 |
Becker-Santos DD, Lonergan KM, Gronostajski RM, Lam WL. Nuclear Factor I/B: A Master Regulator of Cell Differentiation with Paradoxical Roles in Cancer. EBioMedicine 2017;22:2-9. [PMID: 28596133 DOI: 10.1016/j.ebiom.2017.05.027] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
43 |
Cheng L, Zhang S, Wang L, MacLennan GT, Davidson DD. Fluorescence in situ hybridization in surgical pathology: principles and applications. J Pathol Clin Res 2017;3:73-99. [PMID: 28451457 DOI: 10.1002/cjp2.64] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
|